Literature DB >> 5041655

Daunomycin and adriamycin metabolism via reductive glycosidic cleavage.

M A Asbell, E Schwartzbach, F J Bullock, D W Yesair.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5041655

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  7 in total

1.  Carminomycin I is an apoptosis inducer that targets the Golgi complex in clear cell renal carcinoma cells.

Authors:  Girma M Woldemichael; Thomas J Turbyville; W Marston Linehan; James B McMahon
Journal:  Cancer Res       Date:  2011-01-01       Impact factor: 12.701

2.  AKR1B10 induces cell resistance to daunorubicin and idarubicin by reducing C13 ketonic group.

Authors:  Linlin Zhong; Honglin Shen; Chenfei Huang; Hongwu Jing; Deliang Cao
Journal:  Toxicol Appl Pharmacol       Date:  2011-05-26       Impact factor: 4.219

3.  A survey of the anthracycline derivatives in hematology.

Authors:  C Jacquillat; M Weil; M F Auclerc; J Maral; G Schaison; M Boiron; J Bernard
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

4.  7-Deoxy-13-dihydrodaunomycinone in cultures of Streptomyces coeruleorubidus.

Authors:  J Matĕjů; J Vokoun; M Blumauerová; Z Vanĕk
Journal:  Folia Microbiol (Praha)       Date:  1978       Impact factor: 2.099

5.  The persistence of adriamycin in man and rat.

Authors:  P M Wilkinson; G E Mawer
Journal:  Br J Clin Pharmacol       Date:  1974-06       Impact factor: 4.335

Review 6.  Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties.

Authors:  J Bouma; J H Beijnen; A Bult; W J Underberg
Journal:  Pharm Weekbl Sci       Date:  1986-04-25

7.  [The pharmacokinetics of adriamycin and adriamycin-metabolites (author's transl)].

Authors:  G Ehninger; H J Stocker; B Proksch; K Wilms
Journal:  Klin Wochenschr       Date:  1980-09-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.